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Abstract Two hybrid proteins between Pseudomonas eruginosa exotoxin A (PE) and poliovirus protease 2AP” have been generated. One hybrid 
protein contains the poliovirus 2A*” sequence replacing the region of PE corresponding to amino acids 413-607. The other hybrid contains in addition 
the transforming rowth factor sequence. The two hybrid proteins were efficiently synthesized in E. coli cells using the inducible PET vectors. Both 
hybrid toxins cleaved ~220 (eIF-4y) when the recombinant plasmids were transfected in COS cells infected with recombinant vaccinia virus bearing 
the T7 RNA polymerase gene. 
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1. Introduction 
A variety of hybrid toxins and immunotoxins have been 
generated to selectively kill tumor cells and HIV-infected cells. 
In addition, several regions of these toxins have been replaced 
with other protein domains giving rise to hybrid proteins with 
novel functions [1,2]. Perhaps one of the best characterized 
toxin used in this type of studies is Pseudomonas aeruginosa 
exotoxin A (PE), a single-chain polypeptide that contains 613 
amino acids. PE is arranged in several domains: domain Ia (aa 
l-252) involved in binding the toxin to the receptor, domain II 
(253-364) translocates PE across the membrane, domain Ib 
(365-404) of unknown function, and domain III (405-613) en- 
dowed with catalytic activity, inactivates elongation factor 2 by 
ADP-rybosylation [3]. 
Domain I of PE has been replaced by other protein moieties, 
including growth factors and interleukins to target the toxic 
effects of PE to specilic cell types [2,4-6]. Besides the enzymatic 
domain of PE, i.e. domain III, has been replaced with the 
enzyme barnase [7J The resulting hybrid protein was shown to 
display RNAase activity [7j. We reasoned that replacement of 
PE domain III by the poliovirus protease 2AP” would produce 
a hybrid protein able to cleave ~220 (also known as eIF+). 
This hybrid protein would be a very useful tool to analyze the 
function of this initiation factor in mammalian cells. In the 
present report we describe the construction of hybrid toxins 
between PE and poliovirus 2A pro These hybrid proteins retain . 
the 2Ap” activity and are able to cleave ~220 when expressed 
in COS cells. 
2. Materials and methods 
2.1. Construction of expression plasmids 
Vectors containing the 2Ap“ sequence were constructed by standard 
cloning procedures [S]. Plasmid pVC47355 f(+)T was kindly provided 
by Dr. I. Pastan (Bethesda, MD) [7,9]. This plasmid contains the se- 
quences encoding the chime& toxin PE-TGFcz under the control of a 
bacteriophage T7 promoter. Plasmid pPE was prepared from 
pVC47355 f(+)T by digestion with N&I and self-ligating the 4.9 kb 
fragment. 
Two oligonucleotides were designed to hybridize with regions 3386- 
3403 (primer 5’-2A) and 3832-3815 (primer 3’-2A) of poliovirus type 1 
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cDNA from vector pT7XLD, generously provided by Dr. E. Wimmer 
(Stony Brook, NY). The PCR-amplified product containing the se- 
quen& of poliovirub 2A was purified using ihe Gene Clean kitand was 
digested with SacII. Plasmids uVC47355 ff+jT tid DPE were double- 
digested with Sac11 + StuI, &ing rise to’ 4.5 Ad 4.3 kb DNA 
fragments, respectively. These DNA fragments were ligated with 
the PCR-amplified fragment to obtain plasmids PVC-III + 2A 
and pPE-III + 2A, respectively, and the recombmants were 
screened by restriction digestion analyses. These plasmids were then 
used to transform BL21(DE3) E. coli cells [lo]. The region amplified 
by polymerase chain reaction was sequenced by the dideoxy method 
(Sequenase; US Biochemical Corp.). 
2.2. Growth and induction of recombinant bacteria 
Single clones of BL21(DE3) cells, which inducibly express T7 RNA 
pol$erase, containing the indicated plasmid, were grown overnight at 
37“C in LB medium in the nresence of 100 &ml amnicillin. Then the 
cells were diluted lOO-fold ih M9 medium [~]supple&nted with 0.2% 
glucose and antibiotics or in LB medium supplemented with antibiotics. 
When the cultures reached A,, of 0.4-0.6 they were induced by the 
addition of 1 mM IPTG. Rifampicin (Sigma) was used at 150 &ml to 
inhibit transcription by E. coli RNA polymerase. 
2.3. Labelling bacterial proteins 
For labelling the proteins synthesized, aliquots of cultures were col- 
lected and incubated with 5 pCi/ml P’Sbethionine (1.45 Ci/mmol; 
Amersham Corp.) for 15 min at 37°C. The labelled bacteria were 
pelleted for 1 min at 12,000 rpm in an Eppendorf microcentrifuge and 
dissolved in lysis buffer (160 mM Tris-HCI, pH 6.8, 2% SDS, 10% 
glycerol, 100 &M dithiothreitol, and 0.033% Br<mophenol blue). After 
SDS-PAGE, fluorography was carried out with 1 M salicylic acid. The 
gels were dried and exposed to X-AR fihns (Kodak) at -70°C. 
2.4. COS cells and virus 
COS cells were grown in tissue culture dishes (Nunc) and Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 5% newborn 
calf serum. The recombinant vaccinia virus bearing the T7 RNA polym- 
erase (VT7) (kindly given by Dr. Moss, NIH, Bethesda) was grown in 
HeLa cells in DMEM with 2% newborn calf serum. Only the intracel- 
lular virus was collected after freezing and thawing. 
2.5. nansfection of DNAs with Vi7 expression system 
For transfection experiments, COS cells were plated on 24-well dishes 
(Nunc) 24 h before infection with VT7 (m.o.i. 5). After 45 min of virus 
adsorption, a mixture of DNA (0.2 pg/well) and Lipofectin (2 pg/well) 
was added to cells as described by the manufacturer (G&co, BRL). 
Cells were harvested at the times indicated in figure legends. 
2.6. Immunoblot assays 
Samples used for immunoblot analyses were dissolved in sample 
buffer; samples for analyses of ~220 were harvested in sample buffer 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(94)01157-5 
46 I. Novoa et al. IFEBS Letters 355 (1994) 45-48 
Fig. 
The 
1. (A) Primers used for polymerase chain reaction amplification. 
region that hybridizes with poliovirus cDNA and the restriction 
enzyme sites are shown. In the upper part, the poliovirus genome has 
been represented showing the regions complementary to the primers. 
(B) Schematic representation of the hybrid proteins between Pseudo- 
monas exotoxin A and poliovirus 2A Pro. The filled box represents amino 
acids 604-613 of PE. -+ 
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with 1 mM PMSF (phenyhnethyl-sulfony&oride) at the indicated 
times, to avoid degradation of ~220. After boiling, the samples were 
electrophoresed in SDS-PAGE gels as indicated in each figure legend. 
The immunoblot assay was carried out as previously described [ll]. 
Polyclonalp220 antibodies were obtained from rabbits immunized with 
synthetic peptides. 
3. Results 
The cloning and sequencing of the Pseudomonas aeruginosa 
gene encoding exotoxin A has allowed the construction of a 
variety of hybrid toxic proteins [2,4]. Fig. 1 schematically shows 
the hybrids obtained between PE and poliovirus 2A*“. Resi- 
dues 413-607 from PE were replaced by the sequence ncoding 
poliovirus 2A *I0 This construct still retains the last amino acids .
(604-613) of PE, including the sequence REDLK which is im- 
portant for the efficient delivery of the toxin to the cytosol[2]. 
The other construct contained, in addition, the sequences that 
encode for transforming growth factor (TGF). This is impor- 
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Fig. 2. Induction of hybrid proteins between Pseuabmonas exotoxin A and poliovirus 2Ap” . m 8. coli. (A and B) BL21(DE3) E. coli cells bearing 
plasmids pPE-III + 2A or PVC-III + 2A, respectively, were grown and induced with 1 mM IPTG as described in section 2. At the indicated times 
post-induction, proteins were labelled with [%]methionine and analyzed by SDS-PAGE. When indicated, 150 &ml rifampicin was added to the 
cultures 20 min after addition of IPTG. (C) Coomassie blue staining of total protein extracts obtained from BL21(DE3) E. coli cells containing 
pPE-III + 2A or PVC-III + 2A induced with 1 mM IPTG (indicated as +) or not (-) at 3 h post-induction. The position of PE-III + 2A and 
PE + TGF-III + 2A proteins and molecular size markers are indicated. 
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tant to confer a wider range of cell types recognized by this 
hybrid toxin [2]. 
The hybrid genes were generated as described in section 2 
and were placed under the control of a T7 promoter in PET 
vectors. Upon transformation of BL21 (DE3) E. coli cells, 
clones were selected and the synthesis of the hybrid toxins 
assayed. Fig. 2 shows that induction of these clones with IPTG 
gives rise to a prominent protein band that migrates with the 
expected size of the hybrid protein in each case. These bands 
are clearly visible by Coomassie blue staining (Fig. 2C). These 
induced proteins correspond to PE-III + 2A or PE + TGF- 
III + 2A. Pulse-labelling of these clones with [3sS]methionine 
upon induction with both IPTG and rifampicin shows more 
clearly the protein which is induced since rifampicin inhibits the 
A 
PVC-III+ZA pPE-111+2A 
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Fig. 3. (A) Immunoblot analyses of hybrid proteins between PE and 
poliovirus 2Ar”. BL21(DE3) E. coli cells containing pPE-III + 2A or 
PVC-III + 2A were grown and induced with 1 mM IPTG (indicated as 
+) or not (-). At the times indicated, cells were harvested and separated 
by 15% SDS-PAGE, transferred to nitrocellulose membranes and re- 
acted with a specific anti-2A rabbit antiserum. The position of PE- 
III + 2A and PE + TGF-III + 2A proteins and molecular size markers 
are shown. (B) Cleavage of ~220 in COS cells. COS cells grown in 
24-well dishes were infected with recombinant vaccinia virus bearing 
the T7 RNA polymerase (m.o.i. 5 pfit/cell). After virus adsorption, cells 
were transfected with the indicated plasmids using lipofectin, as de- 
scribed in section 2. Samples were collected at 17 h.p.i. and immunoblot 
analyses of ~220 were performed by 7.5% SDS-PAGE with rabbit 
polyclonal ~220 antibody. P, poliovirus-infected HeLa cells; VT7, re- 
combinant vaccinia virus containing the T7 RNA polymerase; Cp, 
cleavage products. 
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background of bacterial protein synthesis. In the case of the 
bacterial clone bearing the construct PVC-III- 2A there are 
several induced polypeptides, two of which had a lower molec- 
ular weight of around 29-3 1 kDa. We believe that one of these 
low MW components may correspond to /I-galactosidase that 
is induced by IPTG treatment [12], while the other polypeptides 
may represent cleavage products. 
In order to identify the nature of these polypeptides, they 
were transferred to a nitocellulose membrane and im- 
munoreacted with specific 2Ar”’ antiserum. Clearly, there is 
only one major prominent polypeptide reacting against this 
antiserum in the clone bearing the PE + TGF-III + 2A con- 
struction (Fig. 3A). This polypeptide migrates with an apparent 
MW of 69 kDa, which corresponds to the expected size of the 
hybrid protein. On the other hand, two major proteins are 
apparent in the clone bearing the construction PE-III + 2A; the 
major one corresponds in size to the hybrid toxin whereas we 
do not know the nature of the lower one. There are several 
possibilities to account for the appearance of this low MW 
component that contains 2AP’” sequences. One is that it is 
generated by cleavage from the major product. Another possi- 
bility is that incorrect initiation of translation takes place in 
phase with the 2A Pro sequence giving rise to a lower MW pro- 
tein. We favor the first possibility, because poliovirus proteases 
are active in cis and tram even as precursor polypeptides. Nev- 
ertheless, the main conclusion from these results is that these 
bacterial clones synthesize a major protein that reacts with 
anti-2Ap” antiserum, indicating that 2APm sequences are pres- 
ent in the hybrid protein. 
Finally, to analyze if these hybrids between PE and polio- 
virus 2Ap” are active in ~220 cleavage, several approaches were 
followed. The first one consisted of the partial purification of 
the hybrid proteins in order to test their effects on culture cells. 
Partially purified preparations were toxic for mouse cells, but 
only after prolonged incubation (about 2 days). Analysis of 
~220 cleavage at this time did not reveal clear results because 
of the dead cells (results not shown). The other approach used 
was to directly express these constructs in mammalian cells. 
Since the hybrid proteins were under the control of a T7 pro- 
moter in PET vectors, they were directly transfected in COS 
cells previously infected with recombinant vaccinia virus carry- 
ing the T7 RNA polymerase gene. Analysis of ~220 after 17 h 
post-infection clearly shows that this factor becomes cleaved 
when the cells were transfected with pPE-III + 2A of 
PVC-III + 2A, but not with control plasmids pPE or pVC47355 
f(+)T (Fig. 3B). The specificity of this cleavage is demonstrated 
because ~220 is degraded only if cells transfected with the 
hybrid constructs are infected by recombinant vaccinia virus. 
4. Discussion 
The mechanisms by which picornaviruses arrest cellular pro- 
tein synthesis after infection is a subject of intense research 
[13-151. Despite the efforts of a number of laboratories, there 
is not as yet a definitive model to account for all the existing 
experimental evidence on the shut-off of host translation by 
picornaviruses. Suggestions that poliovirus blocks host transla- 
tion by proteolytic cleavage of a ~220 polypeptide (eIF-4y), a 
component of initiation factor eIF-4F [16], have not been cor- 
roborated by more recent experimental findings [17-191. This 
lack of knowledge comes, at least in part, from the fact that very 
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little is known about the effects that the expression of individual 
poliovirus genes have in mammalian cells. One approach that 
can be used in the case of poliovirus proteins endowed with 
enzymatic capacity, such as the two proteases 2Ap” and 3C**“, 
should be to introduce these proteins directly into cells, in order 
to analyze their potential detrimental effects on host metabo- 
lism. As an initial step in this direction, we have synthesized 
hybrid proteins between PE and 2AP”. These hybrids still retain 
the 2AP” activity as measured by their capacity to cleave ~220, 
despite the fact that 2Ap” is flanked by other protein sequences 
in both hybrids. Further efforts in this direction would concen- 
trate on the production and purification of one of these hybrid 
proteins in large amounts so as to continue the analyses of its 
effects on culture cells. 
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